• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Two leading Generali investors could seek new CEO -sources

September 11, 2021 by David Barret Leave a Comment

September 11, 2021

By Gianluca Semeraro and Claudia Cristoferi

MILAN (Reuters) -Two leading Generali investors are ready to push to replace current CEO Philippe Donnet if the top Italian insurer’s board fails to reach an accord to keep him in the job, three sources close to the matter said.

The Trieste-based insurer is due to appoint a new board next spring and speculation over Donnet’s future has mounted in recent months as tensions among shareholders simmer.

In a sign battle lines are being drawn, the two Generali investors, Francesco Gaetano Caltagirone and Leonardo Del Vecchio, on Saturday disclosed a pact to consult over decisions concerning Generali..

Donnet’s reappointment is in the hands of Generali’s board which for the first time can submit its own slate of board candidates after the insurer changed its by-laws last year.

The sources said the two businessmen, who struck the pact over a combined 10.95% stake, are ready to file their own list of board nominees. The list would not include the current CEO though he is willing to run for another mandate, they said.

Donnet is already working on a new business plan for Generali due in December after steering the company through the COVID-19 crisis and keeping it on track to fully meet goals under the current plan through to end-2021.

Donnet currently enjoys the backing of Alberto Nagel, the CEO of Milanese bank Mediobanca, which is Generali’s top investor with a 12.9% stake, as well as many board members at the insurer.

Del Vecchio and Caltagirone are also, respectively, the first- and second-biggest investor in Mediobanca.

Over the past year, however, both Caltagirone, whose businesses span construction to publishing, and Del Vecchio, the founder of Ray-Ban owner Luxottica, have been critical of Donnet’s strategy which they deem too cautious in seeking merger and acquisition opportunities.

According to one of the sources, the two businessmen could also propose a new chairman with a well-established international profile to oversee Generali’s growth strategies.

A compromise among shareholders is still possible, another of the sources said, and one solution could be the appointment of a managing director backed by both Del Vecchio and Caltagirone who would work alongside Donnet.

However, positions are still far apart, the sources said, ahead of a key meeting on Sept. 27 when Generali’s board will kick off proceedings to submit its own list of nominees.

Before that, in an apparent attempt to find common ground, Generali non-executive board members will meet on Sept. 14, a fourth source said. Donnet will not attend the meeting as he is an executive member, the source added.

(Reporting by Claudia Cristoferi and Gianluca Semeraro, editing by Valentina Za, Ros Russell and Christina Fincher)

Source Link Two leading Generali investors could seek new CEO -sources

David Barret
David Barret

Related posts:

  1. What 377 Y Combinator pitches will teach you about startups
  2. Tennis-Fearless teenagers and hungry qualifiers light up U.S. Open
  3. South Africa’s former President Zuma placed on medical parole
  4. Tennis-Qualifier Van de Zandschulp tames Argentine battler to reach quarters

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • What Is The Fastest Animal In The World?
  • Would The Burglars Have Survived “Home Alone”? We Asked An Intensive Care Doctor
  • World’s First-Ever Dictionary Of Ancient Celtic Languages Set To Be Created
  • Fresh From Capturing Image Of 3I/ATLAS, NASA’s MAVEN Suffers “Anomaly” And Is No Longer Communicating With Earth
  • Thought “Superflu” Was Bad? Strap In: It’s Norovirus Season In The US
  • Why Does Evolution Turn Everything Into Crabs?
  • Neil deGrasse Tyson And Professor Brian Cox Talk Interstellar Comet 3I/ATLAS And Alien Spacecraft: “It’s Older Than Us”
  • New Species Of Tiny Pumpkin Toadlet Is The Size Of A Pencil Tip, And We Cannot Cope
  • Watch The World’s Most Metal Frog Take Down A Giant “Murder Hornet”
  • Scheduling Cancer Immunotherapy In The Morning May Lower Your Risk Of Death By As Much As 63 Percent
  • Spacetime Vortices Spotted For The First Time As Black Hole Kills A Star
  • The Never-Before-Seen First Stars In The Universe May Have Finally Been Spotted
  • There’s Finally An Explanation For The Longest Known Gamma Ray Burst’s Appearance – But A Key Mystery Remains
  • The Earliest Evidence Of Making Fire Has Been Discovered, Dating To 400,000 Years Ago
  • First X-Ray Image Of Comet 3I/ATLAS Reveals Signature Unseen In Other Interstellar Objects
  • The Surprisingly Scientific Events That Occurred On Christmas Day
  • Humans Are The Smartest And Dumbest Animal Of All Time, Argues Biologist
  • The Final Secret Of Self-Healing Roman Concrete May Have Been Cracked
  • People Are Confused By The Natural Markings On Watermelons That Look Like “Crop Circles”
  • Pica: The Disorder That Makes People Crave And Eat The Inedible
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version